Acadia Pharmaceuticals

FDA rejects Acadia’s bid for Nuplazid approval in dementia-related psychosis
FDA rejects Acadia’s bid for Nuplazid approval in dementia-related psychosis
MedCity News
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
FDA
Flag link:
5 FDA approval decisions to watch in the second quarter
5 FDA approval decisions to watch in the second quarter
BioPharma Dive
FDA
Biogen
aducanumab
Acadia Pharmaceuticals
pimavanserin
AstraZeneca
vaccines
COVID-19
Sanofi
Avalglucosidase alfa
Pfizer
pneumococcal disease
Flag link:
Acadia's surprise Nuplazid snag—and subsequent cold shoulder at FDA—beg more questions than answers
Acadia's surprise Nuplazid snag—and subsequent cold shoulder at FDA—beg more questions than answers
Fierce Pharma
Acadia Pharmaceuticals
FDA
Nuplazid
Parkinson's Disease Psychosis
Flag link:
Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout
Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout
Xconomy
Acadia Pharmaceuticals
M&A
CerSci Therapeutics
post-surgical pain
nerve pain
Flag link:
2 Biotech Stocks Poised to Soar in 2020
2 Biotech Stocks Poised to Soar in 2020
Motley Fool
Acadia Pharmaceuticals
Axsome Therapeutics
M&A
Flag link:
Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis
Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis
Xconomy
Acadia Pharmaceuticals
cilnical trials
Parkinson's Disease Psychosis
dementia-related psychosis
Flag link:
Top 7 Companies in Biotech Beach by Revenue
Top 7 Companies in Biotech Beach by Revenue
BioSpace
Biotech Beach
San Diego
California
Amgen
Neurocrine
Acadia Pharmaceuticals
Retrophin
Tocagen
Mirati Therapeutics
AnaptysBio
Flag link:
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
Flag link:
3 Biotech Stocks That Soared Last Week
3 Biotech Stocks That Soared Last Week
Motley Fool
Acadia Pharmaceuticals
Nuplazid
Mesoblast
Grunenthal
MPC-06-ID
Kodiak Sciences
age-related macular degeneration
Flag link:
Acadia calls early halt to Nuplazid psychosis trial after promising interim results
Acadia calls early halt to Nuplazid psychosis trial after promising interim results
Fierce Pharma
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
Flag link:
Trial win could drive Acadia's Nuplazid to new use
Trial win could drive Acadia's Nuplazid to new use
Biopharma Dive
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
clinical trials
FDA
Flag link:
Upcoming events – Acadia hopes for new indications for Nuplazid
Upcoming events – Acadia hopes for new indications for Nuplazid
EP Vantage
Acadia Pharmaceuticals
antipsychotics
Nuplazid
schizophrenia
dementia
Flag link:
Acadia to Move Experimental Pediatric Rett Syndrome Drug to Phase 3
Acadia to Move Experimental Pediatric Rett Syndrome Drug to Phase 3
Xconomy
Acadia Pharmaceuticals
pediatrics
Rett Syndrome
clinical trials
trofinetide
Flag link:
Justice Department launches probe into Acadia's Nuplazid marketing
Justice Department launches probe into Acadia's Nuplazid marketing
Fierce Pharma
Acadia Pharmaceuticals
Nuplazid
DOJ
drug marketing
Flag link:
Follow-on roundup: Acadia raises $275M, Rocket pockets $55M
Follow-on roundup: Acadia raises $275M, Rocket pockets $55M
BioCentury
Acadia Pharmaceuticals
Rocket Pharmaceuticals
Flag link:
3 Biotech Stocks That Soared This Week
3 Biotech Stocks That Soared This Week
Motley Fool
Viking Therapeutics
Acadia Pharmaceuticals
Corbus Pharmaceuticals
Flag link: